日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Catgut implantation at acupoints improves anti-PD-1 inhibitor efficacy in lung cancer by inducing immune responses and remodeling the tumor microenvironment.

在穴位植入羊肠线可通过诱导免疫反应和重塑肿瘤微环境来提高抗PD-1抑制剂在肺癌中的疗效。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-026-04368-1
Wu Qian, Su Ting, Zhang Yuanyuan, Xiong Yuerong, Hu Xiaoyan, Shao Lijuan, Chen Size
肺癌
免疫/内分泌
PD-1
肿瘤微环境
发表日期：2026
文献求助 收藏

Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma

树突状细胞相关基因对肺腺癌预后和免疫治疗反应的预测价值

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03642-z
Sun, Zihao; Hu, Mengfei; Huang, Xiaoning; Song, Minghan; Chen, Xiujing; Bei, Jiaxin; Lin, Yiguang; Chen, Size
肿瘤
肿瘤免疫
树突状细胞
细胞生物学
树突状细胞
免疫/内分泌
发表日期：2025
文献求助 收藏

In-depth analysis of the safety of CAR-T cell therapy for solid tumors

对CAR-T细胞疗法治疗实体瘤的安全性进行深入分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1548979
Dong, Jiayi; Wu, Jiexiong; Jin, Ye; Zheng, Zhu; Su, Ting; Shao, Lijuan; Bei, Jiaxin; Chen, Size
细胞生物学
T细胞
T细胞
免疫/内分泌
发表日期：2025
文献求助 收藏

Drug functional remapping: a new promise for tumor immunotherapy

药物功能重映射：肿瘤免疫疗法的新希望

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1519355
Dong, Jiayi; Su, Ting; Wu, Jiexiong; Xiang, Yu; Song, Minghan; He, Canfeng; Shao, Lijuan; Yang, Yubin; Chen, Size
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Comprehensive Pan-Cancer Analysis of ZNF668 Reveals the Prognostic and Immunological Significance of ZNF668.

对 ZNF668 进行全面的泛癌分析揭示了 ZNF668 的预后和免疫学意义。

期刊:Current Issues in Molecular Biology
影响因子:3
doi:10.3390/cimb47120997
Hu Xiaoyan, Guo Jiali, Zhong Hua, Huang Wenxin, Chen Size, He Canfeng
免疫/内分泌
发表日期：2025
文献求助 收藏

Chimeric antigen receptor natural killer cell therapy for solid tumors: mechanisms, clinical progress, and strategies to overcome the tumor microenvironment

嵌合抗原受体自然杀伤细胞疗法治疗实体瘤：机制、临床进展及克服肿瘤微环境的策略

期刊:Experimental Biology and Medicine
影响因子:2.7
doi:10.3389/ebm.2025.10841
Xiang, Yu; Dong, Jiayi; Shao, Lijuan; Chen, Size
肿瘤
肿瘤免疫
信号转导
自然杀伤细胞
细胞生物学
肿瘤微环境
发表日期：2025
文献求助 收藏

Resveratrol promotes the differentiation of human umbilical cord mesenchymal stem cells into esophageal fibroblasts via AKT signaling pathway

白藜芦醇通过AKT信号通路促进人脐带间充质干细胞向食管成纤维细胞分化

期刊:International Journal of Immunopathology and Pharmacology
影响因子:3
doi:10.1177/03946320241249397
Xiujing Chen，Zihao Sun，Qian Wu，Lijuan Shao   ，Jiaxin Bei   ，Yiguang Lin         ，Hongjie Chen，Size Chen
Human
信号转导
细胞生物学
发育与干细胞
信号转导
干细胞
成纤维细胞
AKT
PI3K/Akt
发表日期：2024
文献求助 收藏

Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy

岩藻聚糖的免疫增强活性及其与癌症免疫疗法的相关性

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md21020128
Li, Yani; McGowan, Eileen; Chen, Size; Santos, Jerran; Yin, Haibin; Lin, Yiguang
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma

铜凋亡和免疫相关基因特征可预测肺腺癌的免疫治疗反应和预后

期刊:Life-Basel
影响因子:3.4
doi:10.3390/life13071583
Sun, Zihao; Chen, Xiujing; Huang, Xiaoning; Wu, Yanfen; Shao, Lijuan; Zhou, Suna; Zheng, Zhu; Lin, Yiguang; Chen, Size
凋亡
肿瘤
表观遗传
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Metastatic Colorectal Cancer Patient with Microsatellite Stability and Germline BRAC2 Mutation Shows a Complete Response to Olaparib in Combination with a PD-1 Inhibitor and Bevacizumab: A Case Report and Review of the Literature

一例具有微卫星稳定性及种系BRCA2突变的转移性结直肠癌患者接受奥拉帕尼联合PD-1抑制剂和贝伐珠单抗治疗后获得完全缓解：病例报告及文献复习

期刊:Life-Basel
影响因子:3.4
doi:10.3390/life13051183
Song, Minghan; Zeng, Xianrong; Wu, Qian; Huang, Jie; Dong, Jiayi; Shao, Lijuan; Sun, Zihao; Lin, Yiguang; Chen, Size
肿瘤
肠癌
肿瘤免疫
BRCA2
PD-1
发表日期：2023
文献求助 收藏